Huaxi Hospital of Sichuan University.

Chengdu, Sichuan 6100141

0 studies enrolling now · 1 studies all time

What they study most

Idiopathic Pulmonary Fibrosis

Studies at this site

• Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early